- Home
- NUVB vs HAYW Comparison
NUVB vs HAYW Comparison
Compare NUVB & HAYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NUVB | HAYW |
|---|---|---|
| Founded | 2018 | 1925 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electronic Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.4B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | NUVB | HAYW |
|---|---|---|
| Price | $8.47 | $15.79 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 4 |
| Target Price | $10.63 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 10.3M | 1.4M |
| Earning Date | 11-03-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 44.13 |
| EPS | N/A | ★ 0.62 |
| Revenue | $26,748,000.00 | ★ $1,099,855,000.00 |
| Revenue This Year | $609.55 | $6.98 |
| Revenue Next Year | $197.91 | $5.69 |
| P/E Ratio | ★ N/A | $25.90 |
| Revenue Growth | ★ 1137.19 | 9.66 |
| 52 Week Low | $1.54 | $11.10 |
| 52 Week High | $8.95 | $17.73 |
Technical Indicators
Market Signals| Indicator | NUVB | HAYW |
|---|---|---|
| Relative Strength Index (RSI) | 68.52 | 47.13 |
| Support Level | $7.80 | $15.65 |
| Resistance Level | $8.95 | $16.16 |
| Average True Range (ATR) | 0.51 | 0.36 |
| MACD | -0.04 | -0.04 |
| Stochastic Oscillator | 74.78 | 28.47 |
Price Performance
Historical ComparisonAbout NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.
About HAYW Hayward Holdings Inc.
Hayward Holdings is a leading manufacturer of energy-efficient swimming pool equipment and pool automation systems. The company offers a wide range of pool equipment, including pumps, filters, heaters, LED lights, and sanitization. Headquartered in Charlotte, North Carolina, the company has around 2,000 full-time employees. Hayward generated approximately $1.1 billion in revenue in 2024.